---
title: "HUALAN BIOLOGICAL's subsidiary genetic engineering company increased its capital to 300 million, an increase of 50%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253937108.md"
description: "According to Tianyancha's business information, recently, HUALAN BIOLOGICAL Engineering Co., Ltd. underwent a business change, with its registered capital increased from 200 million RMB to 300 million RMB, an increase of 50%. The company was established in June 2013, with An Kang as the legal representative. Its business scope includes research, development, production, and sales of biological products, technology transfer, inspection and testing, and agency processing services; biopharmaceutical technology consulting, and import and export of goods or technology. Shareholder information shows that the company is held by An Kang and HUALAN BIOLOGICAL, with shares of 60% and 40%, respectively"
datetime: "2025-08-21T07:57:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253937108.md)
  - [en](https://longbridge.com/en/news/253937108.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253937108.md)
---

# HUALAN BIOLOGICAL's subsidiary genetic engineering company increased its capital to 300 million, an increase of 50%

According to Tianyancha's business information, recently, HUALAN BIOLOGICAL Engineering Co., Ltd. underwent a business change, with its registered capital increased from 200 million RMB to 300 million RMB, an increase of 50%. The company was established in June 2013, with An Kang as the legal representative. Its business scope includes research, development, production, and sales of biological products, technology transfer, inspection and testing, agency processing services; biopharmaceutical technology consulting, and import and export of goods or technology. Shareholder information shows that the company is held by An Kang and HUALAN BIOLOGICAL, holding 60% and 40% respectively

### Related Stocks

- [002007.CN](https://longbridge.com/en/quote/002007.CN.md)

## Related News & Research

- [CEO.CA's Inside the Boardroom: How Viva Gold is Slashing Costs and De-Risking the Tonopah Gold Project in Nevada | VAUCF Stock News](https://longbridge.com/en/news/287236638.md)
- [Possible Bearish Signals With Remgro Insiders Disposing Stock](https://longbridge.com/en/news/287005043.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [The Mercedes AMG GT Coupe Is An Absolute BEAST!](https://longbridge.com/en/news/287260454.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)